Thought Leadership
Blog | February 06, 2017
Read more
NDCA Allows Evidence of Capped Royalty/Book of Wisdom and Monetarily Unquantified Noninfringing Alternatives
Fish & Richardson
Blog | February 03, 2017
FDA Final Guidance on Nonproprietary Names of Biological Products
Fish & Richardson
Read more
Blog | January 17, 2017
Read more
European Unified Patent Court & Unitary Patent to Open in 2017
Fish & Richardson
Article | January 11, 2017
Read more
21st Century Cures Act: No Cure for an FDA Patent Bias
Pharmaceutical Law & Industry Report
Blog | January 10, 2017
Southern District of Florida Awards Ongoing Royalty and Pre-Judgment Interest
Fish & Richardson
Read more
Blog | January 06, 2017
Full Federal Circuit to Review Appeals of PTAB Time-Bar Decisions
Fish & Richardson
Read more
Q&A | January 03, 2017
Q&A with Michael McKeon: ITC's Powerful Patent Remedies
Read more
Blog | December 30, 2016
EDTX denies exclusion of settlement license and "real estate" apportionment
Fish & Richardson
Read more
Blog | December 23, 2016
The First Amendment Does Not Protect All Off-Label Drug Promotion
Fish & Richardson
Read more
Blog | December 23, 2016
DDE denies request to strike lost profits opinion re non-patented items; addresses test data admissibility
Fish & Richardson
Read more